Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

OBJECTIVE: This study investigated the efficacy and safety of insulin degludec (IDeg) once daily (OD), varying injection timing day to day in subjects with type 1 diabetes. RESEARCH DESIGN AND METHODS: This 26-week, open-label, treat-to-target, noninferiority trial compared IDeg forced flexible (For...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathieu, Chantal, Hollander, Priscilla, Miranda-Palma, Bresta, Cooper, John, Franek, Edward, Russell-Jones, David, Larsen, Jens, Tamer, Søren Can, Bain, Stephen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2013
Materias:
Endocrine Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612802/
https://www.ncbi.nlm.nih.gov/pubmed/23393185
http://dx.doi.org/10.1210/jc.2012-3249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612802/
https://www.ncbi.nlm.nih.gov/pubmed/23393185
http://dx.doi.org/10.1210/jc.2012-3249

Ejemplares similares